Log In Sign Up Premium
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Astrazeneca Plc (AZN)’

Hedge Fund and Insider Trading News: Nelson Peltz, Elliott Management, Three Arrow Capital, Casa Systems Inc (CASA), Eli Lilly and Company (LLY), and More

Unilever has similar problems to those Procter & Gamble faced four years ago, and now has the same activist investor on its board. But times otherwise have moved on.

Keep Reading →

May 31 - Hedge Funds, Insider Trading - Comments

Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying

Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.

Keep Reading →

February 20 - Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: Crispin Odey, Bill Ackman, Steve Cohen, Christopher Hohn, Ultragenyx Pharmaceutical Inc (RARE), Compass Diversified Holdings (CODI), and More

Crispin Odey’s flagship hedge fund lost money again in 2020, deepening the gloom for the bearish manager as he tries to revive his shrinking firm and fights an indecent assault...

Keep Reading →

January 6 - Hedge Funds, Insider Trading - Comments

Tesla, General Motors, Alibaba, and More: Why These Stocks Are in the Spotlight

The extended weekend is now over, and Wall Street is once again paying attention to the U.S.

Keep Reading →

May 28 - News - Comments

Billionaire Ken Fisher is Bullish About These Dividend Stocks

Fisher Investments was founded in 1979 by billionaire Ken Fisher.

Keep Reading →

November 13 - Dividend Stocks, Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: Daniel Loeb, Tom Steyer, Ray Dalio, AstraZeneca PLC (AZN), Alteryx Inc (AYX), and More

Daniel Loeb's hedge fund, Third Point, has trimmed the number of nominees it is making to the Campbell Soup board to five, sources tell CNBC.

Keep Reading →

November 9 - Hedge Funds, Insider Trading - Comments

Druckenmiller’s 4Q13 Portfolio Changes

Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is mostly the same.

Keep Reading →

February 24 - Hedge Funds, News - Comments

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.

Keep Reading →

September 23 - News - Comments

An Excellent Investment in the Biotech Space?

According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease...

Keep Reading →

September 23 - News - Comments

Johnson & Johnson (JNJ), AstraZeneca plc (ADR) (AZN), The Procter & Gamble Company (PG): The Priceless Health Business Every Investor Overlooks

It's arguably health care's biggest name.

Keep Reading →

September 19 - News - Comments

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.

Keep Reading →

September 17 - News - Comments

AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal

Through the years, London-based drugmaker AstraZeneca plc (ADR) (NYSE:AZN) and U.S. pharmaceutical firm Merck & Co., Inc.

Keep Reading →

September 17 - News - Comments

Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013

The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech.

Keep Reading →

September 17 - News - Comments

GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...

Keep Reading →

September 16 - News - Comments

Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?

AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger on a $500 million deal...

Keep Reading →

September 15 - News - Comments

Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?

There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...

Keep Reading →

September 12 - News - Comments

AbbVie Inc (ABBV), AstraZeneca plc (ADR) (AZN): Neurocrine Biosciences, Inc. (NBIX) Nosedives on Mid-Stage Study Results

Investors hate to wake up and find that one of their stocks has opened nearly 30% lower than the prior day's close.

Keep Reading →

September 11 - News - Comments

Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains

I know it's like comparing apples and oranges, but humor me for a moment.

Keep Reading →

September 11 - News - Comments

ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)

Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years.

Keep Reading →

September 10 - News - Comments

AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment

Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought to market.

Keep Reading →

September 4 - News - Comments

AstraZeneca plc (ADR) (AZN), BlackBerry Ltd (BBRY): Tuesday’s Top Upgrades (and Downgrades)

This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.

Keep Reading →

September 3 - News - Comments

AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014

The phrase "PDUFA date" is thrown around frequently when discussing biotech and pharma companies.

Keep Reading →

August 27 - News - Comments

Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction

Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments.

Keep Reading →

August 26 - News - Comments

Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?

At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc.

Keep Reading →

August 24 - News - Comments

AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD): Three New Diabetes Drugs Possibly on the Way Soon

It's no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide.

Keep Reading →

August 20 - News - Comments

Osiris Therapeutics, Inc. (OSIR), Anacor Pharmaceuticals Inc (ANAC), Novavax, Inc. (NVAX): Three Humongous Health-Care Stocks This Week

A rising tide lifts all boats, but the opposite isn't true in the stock market. The major indexes slipped this week, while a handful of health-care stocks soared.

Keep Reading →

August 17 - News - Comments

GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern

GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through travel agencies.

Keep Reading →

August 12 - News - Comments

MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy

In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...

Keep Reading →

August 12 - News - Comments

Medidata Solutions Inc (MDSO), salesforce.com, inc. (CRM): I’m Buying This High-Flying Stock Now

Every month, I select one or more stocks that I'll be buying in real life for my Roth IRA.

Keep Reading →

August 12 - News - Comments

Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape

As human beings it can sometimes be difficult for us to see the good in a bad situation.

Keep Reading →

August 7 - News - Comments

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), AstraZeneca plc (ADR) (AZN): A Safe Investment With Growth Promise

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years.

Keep Reading →

August 6 - News - Comments

3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open.

Keep Reading →

August 2 - News - Comments

Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday.

Keep Reading →

August 1 - News - Comments

Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures

Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market.

Keep Reading →

August 1 - News - Comments

China Petroleum & Chemical Corp (ADR) (SNP), AstraZeneca plc (ADR) (AZN): Three Companies With Dividend Yields You Don’t Want to Miss

Several companies are striving hard to manage their business and retain investors by providing an attractive dividend.

Keep Reading →

July 31 - News - Comments

Three Things You Need to Know From Merck & Co., Inc. (MRK)’s Q2 Earnings

The good news was that the big pharmaceutical company beat earnings estimates. Merck & Co., Inc.

Keep Reading →

July 31 - News - Comments

AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance

AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.

Keep Reading →

July 30 - News - Comments

Bristol Myers Squibb Co. (BMY), AstraZeneca plc (ADR) (AZN): Expanding P/E Saved This Pharma Investment

Three years ago, the company told investors not to worry. It had a plan to replace the $6 billion drug that lost patent protection last year.

Keep Reading →

July 28 - News - Comments

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout.

Keep Reading →

July 24 - News - Comments

Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Three Healthcare Stocks for Growth and Dividends

The healthcare sector has been one of the best sectors for dividend hunters -- most of the companies operating in the sector generate massive cash flow and payout a large chunk...

Keep Reading →

July 24 - News - Comments

AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY): The Diabetes Pipeline With a Clog

Big pharma placed its bets on a new class of diabetes drugs called SGLT2. Last year, buzz surrounded late-stage projects from Johnson and Johnson (NYSE:JNJ), Eli Lilly & Co.

Keep Reading →

July 22 - News - Comments

Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)

The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.

Keep Reading →

July 19 - News - Comments

AstraZeneca plc (ADR) (AZN), Actavis Inc (ACT): Can Fish Oil Help This Drug Giant Regain its Mojo?

AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales of its leading drugs.

Keep Reading →

July 15 - News - Comments

Amarin Corporation plc (ADR) (AMRN) Shares Sink on Secondary Offering

"More means less." Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement of a new public offering.

Keep Reading →

July 9 - News - Comments

The Medicines Company (MDCO), AstraZeneca plc (ADR) (AZN): A Small-Cap Pharmaceutical Company With 2014 in Its Sights

A few months back, Barron's featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO).

Keep Reading →

July 5 - News - Comments

How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?

The promising cancer developer confirmed over the weekend that Amgen had made an offer to acquire Onyx for $120 per share, a 38.2% premium above Friday's close.

Keep Reading →

July 5 - News - Comments

TAL International Group, Inc. (TAL), Annaly Capital Management, Inc. (NLY) – High Yield: Stocks or Bonds?

A few weeks ago, CAPS player Valyooo started a lively debate with a blog entry asking for opinions on stocks vs. high-yield bonds.

Keep Reading →

July 5 - News - Comments

AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid

When screening for health-care dividend stocks, it's tempting to look for the ones with the highest yield.

Keep Reading →

July 5 - News - Comments

ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense

In the last couple of years, the biotechnology industry has been on a roll.

Keep Reading →

July 2 - News - Comments

Merck & Co., Inc. (MRK) Stock Depends on Januvia More Than Ever

Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth.

Keep Reading →

July 1 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Lists

25 Most Powerful Countries in Europe

25 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

11 Largest Property Management Companies in the US

11 Largest Property Management Companies in the US

30 of the World's Most Valuable Private Companies

30 of the World's Most Valuable Private Companies

25 Largest Privately Held Companies in America

25 Largest Privately Held Companies in America

13 Biggest Eyewear Companies in the World

13 Biggest Eyewear Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World

10 Biggest HVAC Companies in the USA

10 Biggest HVAC Companies in the USA

25 Strongest Countries in Europe by Military Power

25 Strongest Countries in Europe by Military Power

13 Biggest Gold Mines in the World

13 Biggest Gold Mines in the World

10 Most Advanced Battery Technologies That Will Power the Future

10 Most Advanced Battery Technologies That Will Power the Future

22 Largest Hunting Companies in the US

22 Largest Hunting Companies in the US

18 Countries That Produce the Most Nuclear Energy

18 Countries That Produce the Most Nuclear Energy

5 Countries That Produce the Most Nuclear Energy

5 Countries That Produce the Most Nuclear Energy

12 Biggest Cloud Providers by Market Share in the World

12 Biggest Cloud Providers by Market Share in the World

5 Biggest Cloud Providers by Market Share in the World

5 Biggest Cloud Providers by Market Share in the World

25 Wealthiest Countries in the World by GDP Per Capita

25 Wealthiest Countries in the World by GDP Per Capita

25 Biggest New Jersey Companies and Stocks

25 Biggest New Jersey Companies and Stocks

25 Biggest Colorado Companies and Stocks

25 Biggest Colorado Companies and Stocks

9 Famous Pyramid Scheme Companies in US History

9 Famous Pyramid Scheme Companies in US History

Top 15 Door and Window Manufacturing Companies in USA

Top 15 Door and Window Manufacturing Companies in USA

12 Biggest Ocean Cleaning Companies and Startups

12 Biggest Ocean Cleaning Companies and Startups

15 Largest Plastic Manufacturing Companies in the World

15 Largest Plastic Manufacturing Companies in the World

14 Countries Where the Official Language is English

14 Countries Where the Official Language is English

20 Biggest Ohio Companies and Stocks

20 Biggest Ohio Companies and Stocks

25 Biggest California Companies and Stocks

25 Biggest California Companies and Stocks

25 Biggest Florida Companies and Stocks

25 Biggest Florida Companies and Stocks

25 Biggest Illinois Companies and Stocks

25 Biggest Illinois Companies and Stocks

25 Countries That Have the Most Debt Per Capita

25 Countries That Have the Most Debt Per Capita

15 Largest Orthopedic Companies in the World

15 Largest Orthopedic Companies in the World

15 Countries That Produce the Most Wind Energy

15 Countries That Produce the Most Wind Energy

5 Countries That Produce the Most Wind Energy

5 Countries That Produce the Most Wind Energy

21 Biggest Airports in the World

21 Biggest Airports in the World

5 Biggest Airports in the World

5 Biggest Airports in the World

15 Biggest Chinese State-Owned Companies

15 Biggest Chinese State-Owned Companies

15 Countries Where Bitcoin is Legal and Illegal

15 Countries Where Bitcoin is Legal and Illegal

12 Countries That Produce the Best Engineers in the World

12 Countries That Produce the Best Engineers in the World

20 Biggest Natural Resources Companies in the World

20 Biggest Natural Resources Companies in the World

15 Biggest Nursing Home Companies in the US

15 Biggest Nursing Home Companies in the US

10 Most Fined Pharmaceutical Companies in the World

10 Most Fined Pharmaceutical Companies in the World

11 Biggest BNPL Companies In The World (Updated)

11 Biggest BNPL Companies In The World (Updated)

Most Profitable Crypto Miners in the Market

Most Profitable Crypto Miners in the Market

15 Most LGBTQ Friendly Companies in the US

15 Most LGBTQ Friendly Companies in the US

15 Companies That Still Test on Animals in 2022

15 Companies That Still Test on Animals in 2022

25 Biggest New York Companies and Stocks

25 Biggest New York Companies and Stocks

15 Most Progressive Companies in America

15 Most Progressive Companies in America

15 Biggest Non-Tech Companies in the World by Market Cap

15 Biggest Non-Tech Companies in the World by Market Cap

15 Most Advanced Countries in Medicine

15 Most Advanced Countries in Medicine

23 Most Powerful Countries in the World Heading Into 2023

23 Most Powerful Countries in the World Heading Into 2023

25 Most Politically Influential Countries in the World

25 Most Politically Influential Countries in the World
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use CCPA - Do Not Sell My Information. ©2022 Koala Guide LLC.